STAT3 inhibitors for cancer therapy

References

• Schindler C, Levy DE, Decker T. JAK-STAT signaling: from interferons to cytokines. J Biol Chem 2007; 282:20059 - 63; http://dx.doi.org/10.1074/jbc.R700016200; PMID: 17502367
   PubMed Web of Science ®Google Scholar
• Frank DA. STAT signaling in the pathogenesis and treatment of cancer. Mol Med 1999; 5:432 - 56; PMID: 10449805
   PubMed Web of Science ®Google Scholar
• Frank DA. STAT3 as a central mediator of neoplastic cellular transformation. Cancer Lett 2007; 251:199 - 210; http://dx.doi.org/10.1016/j.canlet.2006.10.017; PMID: 17129668
   PubMed Web of Science ®Google Scholar
• Bar-Natan M, Nelson EA, Xiang M, Frank DA. STAT signaling in the pathogenesis and treatment of myeloid malignancies. JAK-STAT 2012; 1:55 - 64; http://dx.doi.org/10.4161/jkst.20006
   PubMedGoogle Scholar
• Yue P, Turkson J. Targeting STAT3 in cancer: how successful are we?. Expert Opin Investig Drugs 2009; 18:45 - 56; http://dx.doi.org/10.1517/13543780802565791; PMID: 19053881
   PubMed Web of Science ®Google Scholar
• Mankan AK, Greten FR. Inhibiting signal transducer and activator of transcription 3: rationality and rationale design of inhibitors. Expert Opin Investig Drugs 2011; 20:1263 - 75; http://dx.doi.org/10.1517/13543784.2011.601739; PMID: 21751940
   PubMed Web of Science ®Google Scholar
• Reich NC, Liu L. Tracking STAT nuclear traffic. Nat Rev Immunol 2006; 6:602 - 12; http://dx.doi.org/10.1038/nri1885; PMID: 16868551
   PubMed Web of Science ®Google Scholar
• Ma J, Zhang T, Novotny-Diermayr V, Tan AL, Cao X. A novel sequence in the coiled-coil domain of Stat3 essential for its nuclear translocation. J Biol Chem 2003; 278:29252 - 60; http://dx.doi.org/10.1074/jbc.M304196200; PMID: 12746441
   PubMed Web of Science ®Google Scholar
• Ma J, Cao X. Regulation of Stat3 nuclear import by importin alpha5 and importin alpha7 via two different functional sequence elements. Cell Signal 2006; 18:1117 - 26; http://dx.doi.org/10.1016/j.cellsig.2005.06.016; PMID: 16298512
   PubMed Web of Science ®Google Scholar
• Liu L, McBride KM, Reich NC. STAT3 nuclear import is independent of tyrosine phosphorylation and mediated by importin-alpha3. Proc Natl Acad Sci U S A 2005; 102:8150 - 5; http://dx.doi.org/10.1073/pnas.0501643102; PMID: 15919823
   PubMed Web of Science ®Google Scholar
• Yang J, Liao X, Agarwal MK, Barnes L, Auron PE, Stark GR. Unphosphorylated STAT3 accumulates in response to IL-6 and activates transcription by binding to NFkappaB. Genes Dev 2007; 21:1396 - 408; http://dx.doi.org/10.1101/gad.1553707; PMID: 17510282
   PubMed Web of Science ®Google Scholar
• Pranada AL, Metz S, Herrmann A, Heinrich PC, Müller-Newen G. Real time analysis of STAT3 nucleocytoplasmic shuttling. J Biol Chem 2004; 279:15114 - 23; http://dx.doi.org/10.1074/jbc.M312530200; PMID: 14701810
   PubMed Web of Science ®Google Scholar
• Herrmann A, Vogt M, Mönnigmann M, Clahsen T, Sommer U, Haan S, et al. Nucleocytoplasmic shuttling of persistently activated STAT3. J Cell Sci 2007; 120:3249 - 61; http://dx.doi.org/10.1242/jcs.03482; PMID: 17726064
   PubMed Web of Science ®Google Scholar
• Marg A, Shan Y, Meyer T, Meissner T, Brandenburg M, Vinkemeier U. Nucleocytoplasmic shuttling by nucleoporins Nup153 and Nup214 and CRM1-dependent nuclear export control the subcellular distribution of latent Stat1. J Cell Biol 2004; 165:823 - 33; http://dx.doi.org/10.1083/jcb.200403057; PMID: 15210729
   PubMed Web of Science ®Google Scholar
• Wenta N, Strauss H, Meyer S, Vinkemeier U. Tyrosine phosphorylation regulates the partitioning of STAT1 between different dimer conformations. Proc Natl Acad Sci U S A 2008; 105:9238 - 43; http://dx.doi.org/10.1073/pnas.0802130105; PMID: 18591661
   PubMed Web of Science ®Google Scholar
• Speil J, Baumgart E, Siebrasse JP, Veith R, Vinkemeier U, Kubitscheck U. Activated STAT1 transcription factors conduct distinct saltatory movements in the cell nucleus. Biophys J 2011; 101:2592 - 600; http://dx.doi.org/10.1016/j.bpj.2011.10.006; PMID: 22261046
   PubMed Web of Science ®Google Scholar
• Pilati C, Amessou M, Bihl MP, Balabaud C, Nhieu JT, Paradis V, et al. Somatic mutations activating STAT3 in human inflammatory hepatocellular adenomas. J Exp Med 2011; 208:1359 - 66; http://dx.doi.org/10.1084/jem.20110283; PMID: 21690253
   PubMed Web of Science ®Google Scholar
• Koskela HL, Eldfors S, Ellonen P, van Adrichem AJ, Kuusanmäki H, Andersson EI, et al. Somatic STAT3 mutations in large granular lymphocytic leukemia. N Engl J Med 2012; 366:1905 - 13; http://dx.doi.org/10.1056/NEJMoa1114885; PMID: 22591296
   PubMed Web of Science ®Google Scholar
• Groner B. Determinants of the extent and duration of STAT3 signaling. JAK-STAT 2012; 1:211 - 5; http://dx.doi.org/10.4161/jkst.21469
   PubMedGoogle Scholar
• Yu H, Kortylewski M, Pardoll D. Crosstalk between cancer and immune cells: role of STAT3 in the tumour microenvironment. Nat Rev Immunol 2007; 7:41 - 51; http://dx.doi.org/10.1038/nri1995; PMID: 17186030
   PubMed Web of Science ®Google Scholar
• Darnell JE Jr.. Transcription factors as targets for cancer therapy. Nat Rev Cancer 2002; 2:740 - 9; http://dx.doi.org/10.1038/nrc906; PMID: 12360277
   PubMed Web of Science ®Google Scholar
• Lin J, Buettner R, Yuan YC, Yip R, Horne D, Jove R, et al. Molecular dynamics simulations of the conformational changes in signal transducers and activators of transcription, Stat1 and Stat3. J Mol Graph Model 2009; 28:347 - 56; http://dx.doi.org/10.1016/j.jmgm.2009.08.013; PMID: 19781967
   PubMed Web of Science ®Google Scholar
• Regis G, Pensa S, Boselli D, Novelli F, Poli V. Ups and downs: the STAT1:STAT3 seesaw of Interferon and gp130 receptor signalling. Semin Cell Dev Biol 2008; 19:351 - 9; http://dx.doi.org/10.1016/j.semcdb.2008.06.004; PMID: 18620071
   PubMed Web of Science ®Google Scholar
• Najjar I, Fagard R. STAT1 and pathogens, not a friendly relationship. Biochimie 2010; 92:425 - 44; http://dx.doi.org/10.1016/j.biochi.2010.02.009; PMID: 20159032
   PubMed Web of Science ®Google Scholar
• Kovacic B, Stoiber D, Moriggl R, Weisz E, Ott RG, Kreibich R, et al. STAT1 acts as a tumor promoter for leukemia development. Cancer Cell 2006; 10:77 - 87; http://dx.doi.org/10.1016/j.ccr.2006.05.025; PMID: 16843267
   PubMed Web of Science ®Google Scholar
• Jarnicki A, Putoczki T, Ernst M. Stat3: linking inflammation to epithelial cancer - more than a “gut” feeling?. Cell Div 2010; 5:14; http://dx.doi.org/10.1186/1747-1028-5-14; PMID: 20478049
   PubMed Web of Science ®Google Scholar
• Chin YE, Kitagawa M, Kuida K, Flavell RA, Fu XY. Activation of the STAT signaling pathway can cause expression of caspase 1 and apoptosis. Mol Cell Biol 1997; 17:5328 - 37; PMID: 9271410
   PubMed Web of Science ®Google Scholar
• Avalle L, Pensa S, Regis G, Novelli F, Poli V. STAT1 and STAT3 in tumorigenesis a matter of balance. JAK-STAT 2012; 1:65 - 72; http://dx.doi.org/10.4161/jkst.20045
   PubMedGoogle Scholar
• Darnell JE Jr., Kerr IM, Stark GR. Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins. Science 1994; 264:1415 - 21; http://dx.doi.org/10.1126/science.8197455; PMID: 8197455
   PubMed Web of Science ®Google Scholar
• Seidel HM, Milocco LH, Lamb P, Darnell JE Jr., Stein RB, Rosen J. Spacing of palindromic half sites as a determinant of selective STAT (signal transducers and activators of transcription) DNA binding and transcriptional activity. Proc Natl Acad Sci U S A 1995; 92:3041 - 5; http://dx.doi.org/10.1073/pnas.92.7.3041; PMID: 7708771
   PubMed Web of Science ®Google Scholar
• Ehret GB, Reichenbach P, Schindler U, Horvath CM, Fritz S, Nabholz M, et al. DNA binding specificity of different STAT proteins. Comparison of in vitro specificity with natural target sites. J Biol Chem 2001; 276:6675 - 88; http://dx.doi.org/10.1074/jbc.M001748200; PMID: 11053426
   PubMed Web of Science ®Google Scholar
• Schindler C. STATs as activators of apoptosis. Trends Cell Biol 1998; 8:97 - 8; http://dx.doi.org/10.1016/S0962-8924(98)01233-1; PMID: 9695817
   PubMed Web of Science ®Google Scholar
• Lee CK, Smith E, Gimeno R, Gertner R, Levy DE. STAT1 affects lymphocyte survival and proliferation partially independent of its role downstream of IFN-gamma. J Immunol 2000; 164:1286 - 92; PMID: 10640742
   PubMed Web of Science ®Google Scholar
• Shim SH, Sung MW, Park SW, Heo DS. Absence of STAT1 disturbs the anticancer effect induced by STAT3 inhibition in head and neck carcinoma cell lines. Int J Mol Med 2009; 23:805 - 10; PMID: 19424608
   PubMed Web of Science ®Google Scholar
• Souissi I, Najjar I, Ah-Koon L, Schischmanoff PO, Lesage D, Le Coquil S, et al. A STAT3-decoy oligonucleotide induces cell death in a human colorectal carcinoma cell line by blocking nuclear transfer of STAT3 and STAT3-bound NF-κB. BMC Cell Biol 2011; 12:14; http://dx.doi.org/10.1186/1471-2121-12-14; PMID: 21486470
   PubMed Web of Science ®Google Scholar
• Bromberg JF, Horvath CM, Wen Z, Schreiber RD, Darnell JE Jr.. Transcriptionally active Stat1 is required for the antiproliferative effects of both interferon alpha and interferon gamma. Proc Natl Acad Sci U S A 1996; 93:7673 - 8; http://dx.doi.org/10.1073/pnas.93.15.7673; PMID: 8755534
   PubMed Web of Science ®Google Scholar
• Kumar A, Commane M, Flickinger TW, Horvath CM, Stark GR. Defective TNF-alpha-induced apoptosis in STAT1-null cells due to low constitutive levels of caspases. Science 1997; 278:1630 - 2; http://dx.doi.org/10.1126/science.278.5343.1630; PMID: 9374464
   PubMed Web of Science ®Google Scholar
• Shankaran V, Ikeda H, Bruce AT, White JM, Swanson PE, Old LJ, et al. IFNgamma and lymphocytes prevent primary tumour development and shape tumour immunogenicity. Nature 2001; 410:1107 - 11; http://dx.doi.org/10.1038/35074122; PMID: 11323675
   PubMed Web of Science ®Google Scholar
• Dunn GP, Koebel CM, Schreiber RD. Interferons, immunity and cancer immunoediting. Nat Rev Immunol 2006; 6:836 - 48; http://dx.doi.org/10.1038/nri1961; PMID: 17063185
   PubMed Web of Science ®Google Scholar
• Turkson J, Zhang S, Palmer J, Kay H, Stanko J, Mora LB, et al. Inhibition of constitutive signal transducer and activator of transcription 3 activation by novel platinum complexes with potent antitumor activity. Mol Cancer Ther 2004; 3:1533 - 42; PMID: 15634646
   PubMed Web of Science ®Google Scholar
• Turkson J, Ryan D, Kim JS, Zhang Y, Chen Z, Haura E, et al. Phosphotyrosyl peptides block Stat3-mediated DNA binding activity, gene regulation, and cell transformation. J Biol Chem 2001; 276:45443 - 55; http://dx.doi.org/10.1074/jbc.M107527200; PMID: 11579100
   PubMed Web of Science ®Google Scholar
• Song H, Wang R, Wang S, Lin J. A low-molecular-weight compound discovered through virtual database screening inhibits Stat3 function in breast cancer cells. Proc Natl Acad Sci U S A 2005; 102:4700 - 5; http://dx.doi.org/10.1073/pnas.0409894102; PMID: 15781862
   PubMed Web of Science ®Google Scholar
• Schust J, Sperl B, Hollis A, Mayer TU, Berg T. Stattic: a small-molecule inhibitor of STAT3 activation and dimerization. Chem Biol 2006; 13:1235 - 42; http://dx.doi.org/10.1016/j.chembiol.2006.09.018; PMID: 17114005
   PubMed Web of Science ®Google Scholar
• Siddiquee K, Zhang S, Guida WC, Blaskovich MA, Greedy B, Lawrence HR, et al. Selective chemical probe inhibitor of Stat3, identified through structure-based virtual screening, induces antitumor activity. Proc Natl Acad Sci U S A 2007; 104:7391 - 6; http://dx.doi.org/10.1073/pnas.0609757104; PMID: 17463090
   PubMed Web of Science ®Google Scholar
• Zhang X, Yue P, Page BD, Li T, Zhao W, Namanja AT, et al. Orally bioavailable small-molecule inhibitor of transcription factor Stat3 regresses human breast and lung cancer xenografts. Proc Natl Acad Sci U S A 2012; 109:9623 - 8; http://dx.doi.org/10.1073/pnas.1121606109; PMID: 22623533
   PubMed Web of Science ®Google Scholar
• Gunning PT, Katt WP, Glenn M, Siddiquee K, Kim JS, Jove R, et al. Isoform selective inhibition of STAT1 or STAT3 homo-dimerization via peptidomimetic probes: structural recognition of STAT SH2 domains. Bioorg Med Chem Lett 2007; 17:1875 - 8; http://dx.doi.org/10.1016/j.bmcl.2007.01.077; PMID: 17336521
   PubMed Web of Science ®Google Scholar
• McMurray JS. A new small-molecule Stat3 inhibitor. Chem Biol 2006; 13:1123 - 4; http://dx.doi.org/10.1016/j.chembiol.2006.11.001; PMID: 17113993
   PubMed Web of Science ®Google Scholar
• Jing N, Li Y, Xiong W, Sha W, Jing L, Tweardy DJ. G-quartet oligonucleotides: a new class of signal transducer and activator of transcription 3 inhibitors that suppresses growth of prostate and breast tumors through induction of apoptosis. Cancer Res 2004; 64:6603 - 9; http://dx.doi.org/10.1158/0008-5472.CAN-03-4041; PMID: 15374974
   PubMed Web of Science ®Google Scholar
• Weerasinghe P, Garcia GE, Zhu Q, Yuan P, Feng L, Mao L, et al. Inhibition of Stat3 activation and tumor growth suppression of non-small cell lung cancer by G-quartet oligonucleotides. Int J Oncol 2007; 31:129 - 36; PMID: 17549413
   PubMed Web of Science ®Google Scholar
• Jing N, Zhu Q, Yuan P, Li Y, Mao L, Tweardy DJ. Targeting signal transducer and activator of transcription 3 with G-quartet oligonucleotides: a potential novel therapy for head and neck cancer. Mol Cancer Ther 2006; 5:279 - 86; http://dx.doi.org/10.1158/1535-7163.MCT-05-0302; PMID: 16505101
   PubMed Web of Science ®Google Scholar
• Zhu Q, Jing N. Computational study on mechanism of G-quartet oligonucleotide T40214 selectively targeting Stat3. J Comput Aided Mol Des 2007; 21:641 - 8; http://dx.doi.org/10.1007/s10822-007-9147-6; PMID: 18034310
   PubMed Web of Science ®Google Scholar
• Jing N, Tweardy DJ. Targeting Stat3 in cancer therapy. Anticancer Drugs 2005; 16:601 - 7; http://dx.doi.org/10.1097/00001813-200507000-00002; PMID: 15930886
   PubMed Web of Science ®Google Scholar
• Johnston PA, Grandis JR. STAT3 signaling: anticancer strategies and challenges. Mol Interv 2011; 11:18 - 26; http://dx.doi.org/10.1124/mi.11.1.4; PMID: 21441118
   PubMed Web of Science ®Google Scholar
• Morishita R, Nakagami H, Taniyama Y, Matsushita H, Yamamoto K, Tomita N, et al. Oligonucleotide-based gene therapy for cardiovascular disease. Clin Chem Lab Med 1998; 36:529 - 34; http://dx.doi.org/10.1515/CCLM.1998.090; PMID: 9806454
   PubMed Web of Science ®Google Scholar
• Aoki M, Morishita R, Higaki J, Moriguchi A, Hayashi S, Matsushita H, et al. Survival of grafts of genetically modified cardiac myocytes transfected with FITC-labeled oligodeoxynucleotides and the beta-galactosidase gene in the noninfarcted area, but not the myocardial infarcted area. Gene Ther 1997; 4:120 - 7; http://dx.doi.org/10.1038/sj.gt.3300361; PMID: 9081702
   PubMed Web of Science ®Google Scholar
• Lin MT, Chang CC, Chen ST, Chang HL, Su JL, Chau YP, et al. Cyr61 expression confers resistance to apoptosis in breast cancer MCF-7 cells by a mechanism of NF-kappaB-dependent XIAP up-regulation. J Biol Chem 2004; 279:24015 - 23; http://dx.doi.org/10.1074/jbc.M402305200; PMID: 15044484
   PubMed Web of Science ®Google Scholar
• Leong PL, Andrews GA, Johnson DE, Dyer KF, Xi S, Mai JC, et al. Targeted inhibition of Stat3 with a decoy oligonucleotide abrogates head and neck cancer cell growth. Proc Natl Acad Sci U S A 2003; 100:4138 - 43; http://dx.doi.org/10.1073/pnas.0534764100; PMID: 12640143
   PubMed Web of Science ®Google Scholar
• Tadlaoui Hbibi A, Laguillier C, Souissi I, Lesage D, Le Coquil S, Cao A, et al. Efficient killing of SW480 colon carcinoma cells by a signal transducer and activator of transcription (STAT) 3 hairpin decoy oligodeoxynucleotide--interference with interferon-gamma-STAT1-mediated killing. FEBS J 2009; 276:2505 - 15; http://dx.doi.org/10.1111/j.1742-4658.2009.06975.x; PMID: 19476491
   PubMed Web of Science ®Google Scholar
• Park YG, Nesterova M, Agrawal S, Cho-Chung YS. Dual blockade of cyclic AMP response element- (CRE) and AP-1-directed transcription by CRE-transcription factor decoy oligonucleotide. gene-specific inhibition of tumor growth. J Biol Chem 1999; 274:1573 - 80; http://dx.doi.org/10.1074/jbc.274.3.1573; PMID: 9880535
   PubMed Web of Science ®Google Scholar
• Bene A, Kurten RC, Chambers TC. Subcellular localization as a limiting factor for utilization of decoy oligonucleotides. Nucleic Acids Res 2004; 32:e142; http://dx.doi.org/10.1093/nar/gnh139; PMID: 15498923
   PubMedGoogle Scholar
• Nardozzi J, Wenta N, Yasuhara N, Vinkemeier U, Cingolani G. Molecular basis for the recognition of phosphorylated STAT1 by importin alpha5. J Mol Biol 2010; 402:83 - 100; http://dx.doi.org/10.1016/j.jmb.2010.07.013; PMID: 20643137
   PubMed Web of Science ®Google Scholar
• Meyer T, Vinkemeier U. STAT nuclear translocation: potential for pharmacological intervention. Expert Opin Ther Targets 2007; 11:1355 - 65; http://dx.doi.org/10.1517/14728222.11.10.1355; PMID: 17907964
   PubMed Web of Science ®Google Scholar
• Costa-Pereira AP, Tininini S, Strobl B, Alonzi T, Schlaak JF, Is’harc H, et al. Mutational switch of an IL-6 response to an interferon-gamma-like response. Proc Natl Acad Sci U S A 2002; 99:8043 - 7; http://dx.doi.org/10.1073/pnas.122236099; PMID: 12060750
   PubMed Web of Science ®Google Scholar
• Schiavone D, Avalle L, Dewilde S, Poli V. The immediate early genes Fos and Egr1 become STAT1 transcriptional targets in the absence of STAT3. FEBS Lett 2011; 585:2455 - 60; http://dx.doi.org/10.1016/j.febslet.2011.06.020; PMID: 21723864
   PubMed Web of Science ®Google Scholar
• Souissi I, Ladam P, Cognet JA, Le Coquil S, Varin-Blank N, Baran-Marszak F, et al. A STAT3-inhibitory hairpin decoy oligodeoxynucleotide discriminates between STAT1 and STAT3 and induces death in a human colon carcinoma cell line. Mol Cancer 2012; 11:12; http://dx.doi.org/10.1186/1476-4598-11-12; PMID: 22423663
   PubMed Web of Science ®Google Scholar
• Chen X, Vinkemeier U, Zhao Y, Jeruzalmi D, Darnell JE Jr., Kuriyan J. Crystal structure of a tyrosine phosphorylated STAT-1 dimer bound to DNA. Cell 1998; 93:827 - 39; http://dx.doi.org/10.1016/S0092-8674(00)81443-9; PMID: 9630226
   PubMed Web of Science ®Google Scholar
• Horvath CM, Wen Z, Darnell JE Jr.. A STAT protein domain that determines DNA sequence recognition suggests a novel DNA-binding domain. Genes Dev 1995; 9:984 - 94; http://dx.doi.org/10.1101/gad.9.8.984; PMID: 7774815
   PubMed Web of Science ®Google Scholar
• Lamb P, Seidel HM, Haslam J, Milocco L, Kessler LV, Stein RB, et al. STAT protein complexes activated by interferon-gamma and gp130 signaling molecules differ in their sequence preferences and transcriptional induction properties. Nucleic Acids Res 1995; 23:3283 - 9; http://dx.doi.org/10.1093/nar/23.16.3283; PMID: 7667105
   PubMed Web of Science ®Google Scholar
• Dolinnaya N, Metelev V, Oretskaya T, Tabatadze D, Shabarova Z. Hairpin-shaped DNA duplexes with disulfide bonds in sugar-phosphate backbone as potential DNA reagents for crosslinking with proteins. FEBS Lett 1999; 444:285 - 90; http://dx.doi.org/10.1016/S0014-5793(99)00059-9; PMID: 10050776
   PubMed Web of Science ®Google Scholar
• Laguillier C, Hbibi AT, Baran-Marszak F, Metelev V, Cao A, Cymbalista F, et al. Cell death in NF-kappaB-dependent tumour cell lines as a result of NF-kappaB trapping by linker-modified hairpin decoy oligonucleotide. FEBS Lett 2007; 581:1143 - 50; http://dx.doi.org/10.1016/j.febslet.2007.02.024; PMID: 17328896
   PubMed Web of Science ®Google Scholar
• Sen M, Thomas SM, Kim S, Yeh JI, Ferris RL, Johnson JT, et al. First-in-human trial of a STAT3 decoy oligonucleotide in head and neck tumors: implications for cancer therapy. Cancer Discov 2012; 2:694 - 705; http://dx.doi.org/10.1158/2159-8290.CD-12-0191; PMID: 22719020
   PubMed Web of Science ®Google Scholar
• Sen M, Tosca PJ, Zwayer C, Ryan MJ, Johnson JD, Knostman KA, et al. Lack of toxicity of a STAT3 decoy oligonucleotide. Cancer Chemother Pharmacol 2009; 63:983 - 95; http://dx.doi.org/10.1007/s00280-008-0823-6; PMID: 18766340
   PubMed Web of Science ®Google Scholar
• Pettersen EF, Goddard TD, Huang CC, Couch GS, Greenblatt DM, Meng EC, et al. UCSF Chimera--a visualization system for exploratory research and analysis. J Comput Chem 2004; 25:1605 - 12; http://dx.doi.org/10.1002/jcc.20084; PMID: 15264254
   PubMed Web of Science ®Google Scholar
• Becker S, Groner B, Müller CW. Three-dimensional structure of the Stat3beta homodimer bound to DNA. Nature 1998; 394:145 - 51; http://dx.doi.org/10.1038/28101; PMID: 9671298
   PubMed Web of Science ®Google Scholar
• Valente AJ, Xie JF, Abramova MA, Wenzel UO, Abboud HE, Graves DT. A complex element regulates IFN-gamma-stimulated monocyte chemoattractant protein-1 gene transcription. J Immunol 1998; 161:3719 - 28; PMID: 9759897
   PubMed Web of Science ®Google Scholar
• Wang YF, Yu-Lee LY. Multiple stat complexes interact at the interferon regulatory factor-1 interferon-gamma activation sequence in prolactin-stimulated Nb2 T cells. Mol Cell Endocrinol 1996; 121:19 - 28; http://dx.doi.org/10.1016/0303-7207(96)03840-3; PMID: 8865162
   PubMed Web of Science ®Google Scholar
• Rouyez MC, Lestingi M, Charon M, Fichelson S, Buzyn A, Dusanter-Fourt I. IFN regulatory factor-2 cooperates with STAT1 to regulate transporter associated with antigen processing-1 promoter activity. J Immunol 2005; 174:3948 - 58; PMID: 15778351
   PubMed Web of Science ®Google Scholar
• Pine R, Canova A, Schindler C. Tyrosine phosphorylated p91 binds to a single element in the ISGF2/IRF-1 promoter to mediate induction by IFN alpha and IFN gamma, and is likely to autoregulate the p91 gene. EMBO J 1994; 13:158 - 67; PMID: 8306959
   PubMed Web of Science ®Google Scholar
• Caldenhoven E, Coffer P, Yuan J, Van de Stolpe A, Horn F, Kruijer W, et al. Stimulation of the human intercellular adhesion molecule-1 promoter by interleukin-6 and interferon-gamma involves binding of distinct factors to a palindromic response element. J Biol Chem 1994; 269:21146 - 54; PMID: 7914891
   PubMed Web of Science ®Google Scholar
• Nguyen VT, Benveniste EN. Involvement of STAT-1 and ets family members in interferon-gamma induction of CD40 transcription in microglia/macrophages. J Biol Chem 2000; 275:23674 - 84; http://dx.doi.org/10.1074/jbc.M002482200; PMID: 10823830
   PubMed Web of Science ®Google Scholar
• Fujio Y, Kunisada K, Hirota H, Yamauchi-Takihara K, Kishimoto T. Signals through gp130 upregulate bcl-x gene expression via STAT1-binding cis-element in cardiac myocytes. J Clin Invest 1997; 99:2898 - 905; http://dx.doi.org/10.1172/JCI119484; PMID: 9185513
   PubMed Web of Science ®Google Scholar
• Dong Y, Rohn WM, Benveniste EN. IFN-gamma regulation of the type IV class II transactivator promoter in astrocytes. J Immunol 1999; 162:4731 - 9; PMID: 10202014
   PubMed Web of Science ®Google Scholar
• Gustafson KS, Ginder GD. Interferon-gamma induction of the human leukocyte antigen-E gene is mediated through binding of a complex containing STAT1alpha to a distinct interferon-gamma-responsive element. J Biol Chem 1996; 271:20035 - 46; http://dx.doi.org/10.1074/jbc.271.33.20035; PMID: 8702722
   PubMed Web of Science ®Google Scholar
• Stojanovic T, Wagner AH, Wang S, Kiss E, Rockstroh N, Bedke J, et al. STAT-1 decoy oligodeoxynucleotide inhibition of acute rejection in mouse heart transplants. Basic Res Cardiol 2009; 104:719 - 29; http://dx.doi.org/10.1007/s00395-009-0028-0; PMID: 19352584
   PubMed Web of Science ®Google Scholar
• Xu W, Comhair SA, Zheng S, Chu SC, Marks-Konczalik J, Moss J, et al. STAT-1 and c-Fos interaction in nitric oxide synthase-2 gene activation. Am J Physiol Lung Cell Mol Physiol 2003; 285:L137 - 48; PMID: 12788789
   PubMedGoogle Scholar
• Marrero MB, Bencherif M. Convergence of alpha 7 nicotinic acetylcholine receptor-activated pathways for anti-apoptosis and anti-inflammation: central role for JAK2 activation of STAT3 and NF-kappaB. Brain Res 2009; 1256:1 - 7; http://dx.doi.org/10.1016/j.brainres.2008.11.053; PMID: 19063868
   PubMed Web of Science ®Google Scholar
• Hückel M, Schurigt U, Wagner AH, Stöckigt R, Petrow PK, Thoss K, et al. Attenuation of murine antigen-induced arthritis by treatment with a decoy oligodeoxynucleotide inhibiting signal transducer and activator of transcription-1 (STAT-1). Arthritis Res Ther 2006; 8:R17; http://dx.doi.org/10.1186/ar1869; PMID: 16507120
   PubMedGoogle Scholar
• Magné S, Caron S, Charon M, Rouyez MC, Dusanter-Fourt I. STAT5 and Oct-1 form a stable complex that modulates cyclin D1 expression. Mol Cell Biol 2003; 23:8934 - 45; http://dx.doi.org/10.1128/MCB.23.24.8934-8945.2003; PMID: 14645506
   PubMed Web of Science ®Google Scholar
• Wagner BJ, Hayes TE, Hoban CJ, Cochran BH. The SIF binding element confers sis/PDGF inducibility onto the c-fos promoter. EMBO J 1990; 9:4477 - 84; PMID: 2176154
   PubMed Web of Science ®Google Scholar
• Bellido T, O’Brien CA, Roberson PK, Manolagas SC. Transcriptional activation of the p21(WAF1,CIP1,SDI1) gene by interleukin-6 type cytokines. A prerequisite for their pro-differentiating and anti-apoptotic effects on human osteoblastic cells. J Biol Chem 1998; 273:21137 - 44; http://dx.doi.org/10.1074/jbc.273.33.21137; PMID: 9694869
   PubMed Web of Science ®Google Scholar
• Auernhammer CJ, Bousquet C, Melmed S. Autoregulation of pituitary corticotroph SOCS-3 expression: characterization of the murine SOCS-3 promoter. Proc Natl Acad Sci U S A 1999; 96:6964 - 9; http://dx.doi.org/10.1073/pnas.96.12.6964; PMID: 10359822
   PubMed Web of Science ®Google Scholar
• Kiuchi N, Nakajima K, Ichiba M, Fukada T, Narimatsu M, Mizuno K, et al. STAT3 is required for the gp130-mediated full activation of the c-myc gene. J Exp Med 1999; 189:63 - 73; http://dx.doi.org/10.1084/jem.189.1.63; PMID: 9874564
   PubMed Web of Science ®Google Scholar
• Pallard C, Gouilleux F, Bénit L, Cocault L, Souyri M, Levy D, et al. Thrombopoietin activates a STAT5-like factor in hematopoietic cells. EMBO J 1995; 14:2847 - 56; PMID: 7796811
   PubMed Web of Science ®Google Scholar
• Campbell GS, Meyer DJ, Raz R, Levy DE, Schwartz J, Carter-Su C. Activation of acute phase response factor (APRF)/Stat3 transcription factor by growth hormone. J Biol Chem 1995; 270:3974 - 9; http://dx.doi.org/10.1074/jbc.270.8.3974; PMID: 7876144
   PubMed Web of Science ®Google Scholar